The adrenocorticotrophic hormone of the pituitary gland has been administered to patients with myasthenia gravis mainly on the basis of the following observations and inferences: 1 ) the immediate cause of the symptoms of myasthenia gravis is a decrease Qf acetylcholine synthesis;
2 ) administration of the adrenocorticotrophic hormone increases asetylcholine synthesis in vivo :' 3 ) increase of the lymphatic tissue (round-cell infiltration of various organs, mainly striated muscle5 and "hyperfunctioning" thymus6 have been found in patients with myasthenia gravis. Tissue fractionation studies7J have shown that one of the sources of the substances that inhibit acetylcholine synthesis is the thymus. Administration of the adrenocorticotrophic hormone induces reduction in the mass of the thymus and the lymphatic tissue;9J0 4) removal of the pituitary gland in rats induces changes in the electromyo- gramll that closely resemble the abnormalities noted in patients with myasthenia gravis; 1 2 9 1 3 5 ) the pituitary gland of several patients who died of myasthenia gravis showed accumulation of an eosinophilic colloid material suggesting altered function of the gland.l4-l8 This report aims to illuminate the nature of myasthenia gravis by a further analysis of its phenomenology. Therapeutic implications are outside its scope.
Material. Five patients with myasthenia gravis were women aged 24 (H.L.), 29 (J.R.), 31 (M.Y.), 37 ( A S . ) , and 45 (R.G.) years who had had myasthenia gravis for 4, 17, 10, 13, and 9 years, respectively. During the 3 years before this special study begun the patients experienced minor transient fluctuations but no long lasting or significant changes in their clinical states. They received a total of 300, 45, 180, 112, and 150 mg of neostigmine bromide a day, distributed over the waking hours, taken in from 3 to 6 hourly intervals. H.L. received also 75 mg of ephedrine sulfate, 3 g of potassium chloride, and 0.39 g of guanidine hydrochloride a day; R.G. also received 25 mg of ephedrine sulfate and 3 g of potassium chloride a day. The patients had had, in dmifferent degree of severity anorexia, general weakness, ptosis of the eyelids, weakness and easy fatiguability of the muscles of the palate, tongue, face, deglutition, arms, and legs.
Method. Various tests were performed 11 Torda, C., and Wolff, H. G., Am. J. Physi.Ol., with the patients with myasthenia gravis for one week. Thereafter, the patients were administered intramuscularly adrenocorticotrophic hormone in amounts of 20 mg every 6 hours for 5 days. Tests were performed during the administration of the hormone, for 4 days thereafter, and, at biweekly intervals for another 12 weeks. The following tests were per formed.
Hectromyography. Muscle action potential records were taken during repetitive indirect percu taneous stimulation of the ulnar nerve by 10 and 30 pulses per second for 30 seconds, with a stimulus of supramaximal intensity and of one millisecond duration. The method was described by Harvey and Mas-landT3 and Torda and W01ff.l~ The records were taken daily at the same time of the day, 3 hours after administration of neostigmine bromide during the control period and the period of administration of the hormone, and from 6 to 15 hours after administration of neostigmine bromide thereafter.
Myography. Muscle function was also tested by an ergograph immediately after completion of the electromyograms. The ergograph consisted of a heavy spring attached to an isotonic lever writing on a kymograph. The spring was stretched 2.5 cm once a second by the index and middle finger of the right hand exerting a tension of 15 kg. Acetylcholine s yrzthesis. Acetylcholine synthesis in the presence of the blood serum was studied following the method described by Torda and Wolff.2 The method consists of incubation of a tissue containing choline acetylase with blood serum and determination of the amount of acetylcholine formed during the period of incubation. The amount of acetylcholine synthesized in the presence of serum from healthy controls averaged 2.08 pg t 7% per 100. mg tissue containing the enzyme.
Resutts. During the 5 days of administration of ACTH all patients experienced a gradually increasing disability lasting until the second day after the completion of the injections. Thereafter, the patients exhibited increased well being, they began to reduce the daily intake of neostigmine bromide spontaneously (H.L. from 300 mg to 45 mg; M.Y. from 150 mg to 15 mg; A.S. from 112 mg to 15 mg; R.G. from 180 rng to 90 mg; and J.R. from 45 mg to 15 mg) and omitted the other medications. A partial remission of the symptoms occurred in a11 instances manifesting itself in marked decrease of muscle weakness, the easy fatiguabili The ptosis of the eyeli easy fatiguability of t tongue, face, deglutition, arms, and legs became 'less evident. However, the remission was incomplete,< the muscle groups most severely involved in each patient showed only a partial recovery, as is to be expected after a muscle dysfunction of several years duration. Though not clearly de probable that there is some dw improvement in muscle function with the lapse of time. This incomplete remission persisted from the completion of administration of the hormone to the writing of this report (approximately 3 months).
Electromyography. Healthy subjects maintained the muscle action potential unaltered during repetitive indirect stimulation with 18 pulses per second for 3 0 seconds (Fig. 1A) I and nearly unaltered (average decrease of 12%) during stimulation with 30 pulses per second for 30 seconds.12J3 Before administration of the hormone patients H.L., M.Y., AS., and R.G. exhibited the known decline of the amplitude of muscle action potential during repetitive indirect stimulation. The decline of the amplitude exceeded in all instances 35% on stimulation with 10 pulses per second for 30 seconds and 55% on stimulation with 10 pulses per second for 30 seconds ( Fig. 1B-1E ). During the period of administration of the hormone the abnormalities noted in the electromyograms of the patients gradually decreased. After completion of ,administration of the hormone and while on reduced nkdication the patients were so altered as to maintain the amplitude of action potential during repetitive indirect stimulation in a manner resembling that of healthy subjects. Patient J.R. had before and after administration of the hormone a normal electromycgram ( Fig. 1F) as commonly occurs in patients mildly to moderately ill with myasthenia gravis. The electromyograms re-F ' G . 1 . Effect of adreiiocorticott~~)~)lii~ horiiioiie oil muscle tic t ion pot eiitia 1 du ri iig wpet i t i w iii r l i i~~. i percut:riieous stimulation of tlic nlniii* i i t ' r n s wi?lk 10 pulses per secoiid.
Coluinn 1 represents ilcti011 po,tenti;il wcor(l+ taken dul-ing the first fcw pulses t)f :I 30 s c c o~d stimulation period. CIoluinn 2 reprcscnts rcv-olds taken at the end of the 30 second sti~nulatioii period.
Colui~iii 3 reprcwwts iictioii 1)oteati:ll yecords taken during the first f(w-pulscs of a 30 second stimulatioii pei4od tlic thiid d:iy :iftcr v m ipletion of tlie series of adniinistra tions of t l i c h hormone. Coluiiin 4 represcvts ri1cwcls t:iktw :it the end of tlie 30 second stiniulation lwriod. Records iii column 1 are coiiiparal)le wit11 rclcoids in column 2 of tlic saiiie line :ind records in c.olunin 3 are comparable with tltosc. of eoluiiiii 4 of tlic same line since the positioii of the clcctrodcs rvmained unchanged during tlie 30 sccoiid stiniu1:ttion period. Records iii coluinii 3 i1 re iiot coin1);~riiMi~ with those i n column 1 of tlic saiiie line sinec tlic rcvording electrodes could not be placed in exactly the same positioii on successive days. I n all records the sweep circuit of tlie oscilloscope was synchronized with the stimulator so tlia t successive stimuli and muscle action potcintiwls were superimposed on the screen of the cathode ray tube. Qiwup A contaiiis rccords taken from a 1rt~;iltliy control; group B records from paticwt H.L., group C records from M.Y., group I> records from AS., group E records from R.G., and group F records fom J.R. mained normal up to the writing of the pres-ent report (approximately 3 months).
iMyography.
The 10 control women stretched the spring on the average 150 times before occurrence of fatigue. Before administration of the hormone the patients with myasthenia gravis the average number of contractions (10 exper.) before occurrence of fatigue were 31 (R.G.); 44 (A.S.); 47 (&I.\'.): 75 (H.L.), and 110 (J.R.). During the period of administration of the hormone the number of contractions slightly and gradually increased. After completion of administration of the hormone the work performance continued to increase and reached the fifth day the maximum. This was 105 (R.G.); 120 ( A S . ) ; 180 (M.Y.); 250 (H.L.); and 175 (J.R.). Although this test involves motivation, such sudden and dramatic increase in performance suggests an improvement of the function of the neuromuscular system per se. The improved work performance persisted for the past 3 months.
Acetylcholine synthesis. In the presence of serum of the patients with myasthenia gravis the synthesis of acetylcholine as compared to healthy control subjects decreased by 55 (R.G.); 50 (H.L.); 42 (M.Y.); 40 ( A S . ) , and 2 5 (J.R.) %. In the presence of blood serum taken the third day after completion of administration of the hormone and biweekly thereafter during the past three months the ability of serum to support acetylcholine synthesis approximated normal values. Decreased acetylcholine synthesis in the presence of serum is specific for myasthenia gravis. The more severe the myasthenia gravis the less well the serum supports the activity of choline acetylase.
Comment. Administration of adrenocorticotrophic hormone to patients with myasthenia gravis was first begun by Torda and Wolff .4~ l9 Beginnings of remission were observed in the 2 patients treated in the New York Hospital. Because satisfactory objective procedures testing neuromuscular function per se had not been elaborated in this laboratory at the time inferences concerning the effect of the hormone on patients with myasthenia gravis were deferred. A remis-sion of the symptoms of myasthenia gravis in a moderately ill woman after administration of the hormone was reported by Soffer and collaboratorszo without application of ob jective testing procedures. The transitory impairment observed during the period of administration of the hormone was also observed by Hellman.21 The increased general disability during the administration of the hormone may be due to changes in electrolyte distribution,25 and in various metabolic processes (increase of secretion of some steroid hormone,22-20 adverse effect on carbohydrate metabolism25 and decrease of glutathione content of blood.22) These processes apparently offset the gradually improving function of the neuromuscular apparatus per se. 19 The above investigations indicate that administration of the adrenocorticotrophic hormone induces changes suggesting the begin-20SoRer, I. J., Gabdove, J. L., Laqueur, €€. €'., Volterra, M., Jacobs, M. D., and Sussman, M. L., Sinai Hosp., 1948, 15, 73.  '1 Hellman, L., Fed. Proc., 1949, 8, 72 . Entlocr., 1948, 8, 1. nings of an incomplete remission in patients with myasthenia gravis. If the view suggested by this be valid, i.e., that the immediate cause of the symptoms of patients with myasthenia gravis is a decrease in the synthesis of acetylcholine, then the observation that administration of the hormone increases the synthesis of acetylcholine4 becomes extremely .pertinent to an understanding of the apparent remission of symptoms observed in patients with myasthenia gravis after administration of the adrenocorticotrophic hormone. Because of its long lasting effects, it is inferred that the adrenocorticotrophic hormone acts upon some basic regulatory mechanism.
J . Mozint
1. Five patients moderately to severely ill with myasthenia gravis received 400 mg adrenocorticotrophic hormone given in amounts of 20 mg every 6 hours.
2. Changes that may indicate the beginnings of an incomplete remission occurred after completion of the injections. These changes consisted of decrease of the symptoms and outward manifestations of muscle dysfunction, disappearance of the abnormalities noted in the electromyogram, increased work performance on the ergograph, and increase to normal of the ability of serum to support acetylcholine synthesis. The incomplete remission is long lasting.
